FDA Probes Death of Boy in Brazil
Digest more
23hon MSN
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and devices reviews.
The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in Minnesota.
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, was upgraded to a Class II recall on July 23. Class II recalls occur when use of the drug poses a moderate public health risk, according to the FDA.
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
Explore more
FDA Recalls Single-Serve Coffee Pods Over Potentially Toxic Brewing Risk originally appeared on Men's Fitness. Keurig users, beware. A popular coffee brand has issued a voluntary recall of its single-serve coffee pods.
Mondelēz Global announced a recall for various sizes of Ritz peanut butter cracker sandwiches over possible undeclared allergens.
2don MSN
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time when many experts say that access to the products has become especially important.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals are ahead.
The Food and Drug Administration has closed an investigation into a listeria outbreak that killed one person and sickened 10 in several western states, health officials announced Thursday.
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI as “hallucinating.” The AI will also misrepresent research, according to these employees.